E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/14/2005 in the Prospect News Biotech Daily.

Fitch rates Boston Scientific notes A

Fitch Ratings said it assigned an A rating to Boston Scientific Corp.'s planned $600 million senior unsecured notes issue.

At the same time Fitch affirms the company's current ratings, including the senior unsecured notes at A, issuer default rating at A, $2 billion unsecured bank credit facility at A and commercial paper at F1.

The agency said Boston Scientific's ratings reflect the company's strong credit profile characterized by robust cash flow, modest leverage, stable margins and favorable strategic positions in several established and emerging technologies.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.